Laboratory testing for TEMs in blood

The Canadian Partnership Against Cancer has unveilled a new study analyzing the effects of Tie-2 Expressing Monocytes (TEMs). TEMs are blood cells present in both healthy people as well as patients afflicted with cancer. The cells are seen as playing a key role in "starving tumours of their blood supply" and thus may prevent certain types of cancers. The researchers' goal is to develop tests that will monitor patients who are prescribed drugs that potentially target blood vessel growth. For more information on this trial, click here.